NL149797B - PROCESS FOR PREPARING A CARBAMOYL GROUP CONTAINING OXAZOLE DERIVATIVE WITH ANTI-INFLAMMATORY ACTION AND A PROCESS FOR PREPARING A MEDICINAL PRODUCT CONTAINING THIS COMPOUND AND CONTAINING THIS COMPOUND. - Google Patents

PROCESS FOR PREPARING A CARBAMOYL GROUP CONTAINING OXAZOLE DERIVATIVE WITH ANTI-INFLAMMATORY ACTION AND A PROCESS FOR PREPARING A MEDICINAL PRODUCT CONTAINING THIS COMPOUND AND CONTAINING THIS COMPOUND.

Info

Publication number
NL149797B
NL149797B NL737300326A NL7300326A NL149797B NL 149797 B NL149797 B NL 149797B NL 737300326 A NL737300326 A NL 737300326A NL 7300326 A NL7300326 A NL 7300326A NL 149797 B NL149797 B NL 149797B
Authority
NL
Netherlands
Prior art keywords
preparing
compound
carbamoyl group
medicinal product
inflammatory action
Prior art date
Application number
NL737300326A
Other languages
Dutch (nl)
Other versions
NL7300326A (en
Inventor
G Tarzia
Original Assignee
Lepetit Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit Spa filed Critical Lepetit Spa
Publication of NL7300326A publication Critical patent/NL7300326A/xx
Publication of NL149797B publication Critical patent/NL149797B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • A61K31/4211,3-Oxazoles, e.g. pemoline, trimethadione

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL737300326A 1972-08-07 1973-01-10 PROCESS FOR PREPARING A CARBAMOYL GROUP CONTAINING OXAZOLE DERIVATIVE WITH ANTI-INFLAMMATORY ACTION AND A PROCESS FOR PREPARING A MEDICINAL PRODUCT CONTAINING THIS COMPOUND AND CONTAINING THIS COMPOUND. NL149797B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2795872 1972-08-07

Publications (2)

Publication Number Publication Date
NL7300326A NL7300326A (en) 1974-02-11
NL149797B true NL149797B (en) 1976-06-15

Family

ID=11222675

Family Applications (1)

Application Number Title Priority Date Filing Date
NL737300326A NL149797B (en) 1972-08-07 1973-01-10 PROCESS FOR PREPARING A CARBAMOYL GROUP CONTAINING OXAZOLE DERIVATIVE WITH ANTI-INFLAMMATORY ACTION AND A PROCESS FOR PREPARING A MEDICINAL PRODUCT CONTAINING THIS COMPOUND AND CONTAINING THIS COMPOUND.

Country Status (23)

Country Link
JP (1) JPS5030619B2 (en)
KR (1) KR780000069B1 (en)
AR (1) AR200007A1 (en)
AT (1) AT322551B (en)
AU (1) AU477231B2 (en)
BE (1) BE794096A (en)
CH (1) CH544105A (en)
CS (1) CS177127B2 (en)
DD (1) DD106387A5 (en)
DE (1) DE2301030A1 (en)
ES (1) ES417638A1 (en)
FR (1) FR2195430B1 (en)
GB (1) GB1374345A (en)
HU (1) HU164781B (en)
IE (1) IE36941B1 (en)
IL (1) IL40904A (en)
LU (1) LU66643A1 (en)
NL (1) NL149797B (en)
NO (1) NO137550C (en)
RO (1) RO63442A (en)
SE (1) SE376236B (en)
SU (1) SU511003A3 (en)
ZA (1) ZA728259B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD112905A5 (en) * 1971-09-02 1975-05-12 Snam Progetti
US4110256A (en) * 1976-06-22 1978-08-29 Nippon Soken, Inc. Catalyst for reforming fuel and method for producing same
JPS59125900U (en) * 1983-02-10 1984-08-24 マルヤス機械株式会社 assembly line equipment
DE3425118A1 (en) * 1984-07-07 1986-01-16 Boehringer Mannheim Gmbh, 6800 Mannheim NEW REDOX INDICATORS
JPS6133499U (en) * 1984-07-30 1986-02-28 中西金属工業株式会社 Pallets for manufacturing electrical products
DE69132006T2 (en) * 1990-11-30 2000-08-03 Otsuka Pharma Co Ltd THIAZOLE DERIVATIVES AS INHIBITORS OF ACTIVE OXYGEN
GB0709031D0 (en) 2007-05-10 2007-06-20 Sareum Ltd Pharmaceutical compounds
WO2010111059A1 (en) 2009-03-23 2010-09-30 Merck Sharp & Dohme Corp. P2x3 receptor antagonists for treatment of pain
GB201202027D0 (en) 2012-02-06 2012-03-21 Sareum Ltd Pharmaceutical compounds
EP2634185B1 (en) 2012-03-02 2016-01-13 Sareum Limited TYK2 kinase inhibitors
GB201617871D0 (en) 2016-10-21 2016-12-07 Sareum Limited Pharmaceutical compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1226548A (en) * 1967-06-14 1971-03-31 Wyeth John & Brother Ltd

Also Published As

Publication number Publication date
KR780000069B1 (en) 1978-03-30
CS177127B2 (en) 1977-07-29
AT322551B (en) 1975-05-26
SU511003A3 (en) 1976-04-15
IL40904A (en) 1975-12-31
DD106387A5 (en) 1974-06-12
IE36941L (en) 1974-02-07
JPS4945067A (en) 1974-04-27
ES417638A1 (en) 1976-02-01
JPS5030619B2 (en) 1975-10-02
SE376236B (en) 1975-05-12
AU477231B2 (en) 1976-10-21
NO137550C (en) 1978-03-15
FR2195430A1 (en) 1974-03-08
AR200007A1 (en) 1974-10-15
NL7300326A (en) 1974-02-11
DE2301030A1 (en) 1974-02-28
BE794096A (en) 1973-05-16
LU66643A1 (en) 1973-02-14
HU164781B (en) 1974-04-11
RO63442A (en) 1978-07-15
GB1374345A (en) 1974-11-20
CH544105A (en) 1973-11-15
FR2195430B1 (en) 1976-04-09
ZA728259B (en) 1973-07-25
AU5698273A (en) 1974-12-19
NO137550B (en) 1977-12-05
IL40904A0 (en) 1973-01-30
IE36941B1 (en) 1977-03-30

Similar Documents

Publication Publication Date Title
NL179187C (en) METHOD FOR PREPARING A MEDICINAL PRODUCT A FORMED MEDICINE; AND A METHOD FOR PREPARING MEDICINAL COMPOUNDS.
NL183722C (en) PROCESS FOR THE PREPARATION OF A MEDICINAL PRODUCT WITH ANTI-INFLAMMATORY ACTION, AND FOR COMPOUNDS, SUITABLE FOR USE IN THIS MEDICINAL PRODUCT.
NL7415577A (en) PROCESS FOR THE PREPARATION OF A MEDICINAL PRODUCT WITH CENTRAL-DEPRESSIVE, ANESTHETIC -NARCOTIC ACTION.
NL144276B (en) PROCESS FOR THE PREPARATION OF BRONCHOLYTIC ACTIVE COMPOUNDS AND FOR THE PREPARATION OF A MEDICINAL PRODUCT WITH BRONCHOLYTIC ACTION.
NL168833B (en) METHOD FOR PREPARING OR MANUFACTURING A MEDICINAL PRODUCT WITH ANTIDEPRESSIVE ACTION AND METHOD FOR PREPARING AN ISOXAZOLE COMPOUND SUITABLE FOR USE BY THE FOREGOING PROCESS
NL7412060A (en) METHOD OF PREPARING A MEDICINAL PRODUCT WITH ANTI-INFLAMMATORY ACTION.
NL149797B (en) PROCESS FOR PREPARING A CARBAMOYL GROUP CONTAINING OXAZOLE DERIVATIVE WITH ANTI-INFLAMMATORY ACTION AND A PROCESS FOR PREPARING A MEDICINAL PRODUCT CONTAINING THIS COMPOUND AND CONTAINING THIS COMPOUND.
NL176267C (en) PROCESS FOR PREPARING A PHARMACEUTICAL PREPARATION AND A CEPHALOSPORIC ACID DERIVATIVE WITH ANTI-BAKERIAL ACTION.
NL179583C (en) PROCESS FOR PREPARING A MEDICINAL PRODUCT WITH ANTI-INFLAMMATORY ACTION, AND PROCESS FOR PREPARING MEDICINAL AROYL SUBSTITUTED PENYLACACIC ACID DERIVATIVES.
NL7412745A (en) PROCESS FOR THE PREPARATION OF A MEDICINE WITH ANTI-INFLAMMATORY ACTION.
NL161444C (en) PROCESS FOR THE PREPARATION OF A MEDICINAL PRODUCT WITH ANTI-ARRHYTMIC ACTION, FORMED MEDICINAL PRODUCT WITH SUCH ACTION AND PROCESS FOR THE PREPARATION OF A UREA DERIVATIVE.
NL150436B (en) METHOD OF PREPARING A MEDICINAL PRODUCT WITH ANOREXIGENIC ACTION.
NL151987B (en) METHOD FOR THE PREPARATION OF A MEDICINAL PRODUCT EFFECTIVE AGAINST ARTERIOSCLEROSIS, A MEDICINAL PRODUCT WITH SUCH ACTION AND PROCESS FOR THE PREPARATION OF THE ACTIVE COMPOUNDS.
NL178595C (en) METHOD FOR PREPARING A MEDICINAL PRODUCT WITH HYPOGLYCEMIC AND HYPOLIPEMIC ACTION, AND METHOD FOR PREPARING DERIVATIVES OF SUBSTITUTED PYRAZINIC CARBONIC ACIDS.
NL176078C (en) PROCESS FOR PREPARING A DIGITOXIGENIN-ALFA-L-ARABINOSIDE DERIVATIVE, PROCESS FOR PREPARING A CARDI-ACTIVE MEDICINAL PRODUCT, AND FORMED MEDICINES OBTAINED THEREFORE.
NL7604502A (en) PROCESS FOR THE PREPARATION OF A MEDICINAL PRODUCT WITH ANTI-IFLAMMATORE ACTION, A MEDICINAL PRODUCT WITH SUCH ACTION AND A PROCESS FOR PREPARING THE ACTIVE COMPOUNDS.
NL179479C (en) PROCESS FOR PREPARING A MEDICINAL PRODUCT WITH VALUABLE THERAPEUTIC ACTION, AND PROCESS FOR PREPARING MEDICINAL COMPOUNDS FOR USE THEREOF
NL183763C (en) METHOD FOR PREPARING OR MANUFACTURING A MEDICINAL PRODUCT WITH ANTI-INFLAMMATORY EFFECT, AND METHOD FOR PREPARING 3,20-DIOXO-4-PREGNINE COMPOUNDS
NL183187C (en) PROCESS FOR THE PREPARATION OF BENZOYLINDOLIN-2-ON DERIVATIVES, AND FOR A PHARMACEUTICAL PRODUCT, CONTAINING THESE COMPOUNDS
NL171806C (en) METHOD FOR PREPARING A MEDICINAL PRODUCT WITH ANALGETIC AND / OR ANTI-COUGHING ACTION, AND METHOD FOR PREPARING A BENZAZONINE COMPOUND
NL7506327A (en) PROCESS FOR THE PREPARATION OF A MEDICINAL PRODUCT WITH ANTI-INFLAMMATORY ACTION, A MEDICINAL PRODUCT WITH SUCH ACTION AND A PROCESS FOR THE PREPARATION OF THE ACTIVE COMPOUNDS.
NL176079C (en) METHOD FOR PREPARING A DERIVATIVE OF GITOXIGENIN-DIGITOXOSIDE, METHOD FOR PREPARING A CARDIOACTIVE MEDICINAL PRODUCT AND FORMED MEDICINE THEREFORE
NL149800B (en) PROCESS FOR PREPARING A MEDICINAL PRODUCT WITH ANOREXIGENIC AND ANXIOLYTIC ACTION.
NL7416544A (en) PROCESS FOR THE PREPARATION OF A MEDICINAL PRODUCT WITH ANALGETICAL ACTION, A PREPARED MEDICINAL PRODUCT WITH SUCH ACTION AND A PROCESS FOR THE PREPARATION OF MEDICINAL COMPOUNDS.
NL163119C (en) PROCESS FOR PREPARING A MEDICINAL PRODUCT WITH ANTI-LEUKEMIC ACTION AND PROCESS FOR PREPARING A 1- (2-HALOGENETHYL) -1-NITROSO-UREUM COMPOUND.

Legal Events

Date Code Title Description
VJC Lapsed due to non-payment of the due maintenance fee for the patent or patent application
NL80 Information provided on patent owner name for an already discontinued patent

Owner name: LEPETIT